Re: Wolfe et al. Do rheumatology cost-effectiveness analyses make sense?
Brennan
A
A
Bansback
N
N
D018501:Antirheumatic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006801:Humans; D017059:Models, Econometric; D012216:Rheumatic Diseases / Q000191:economics*
D018501:Antirheumatic Agents